Skip to main content

Cystatins

  • Living reference work entry
  • First Online:
Encyclopedia of Cancer

Synonyms

Thiol-protease inhibitors; Thiostatins; TPI

Definition

Cystatins were originally defined as endogenous inhibitors of thiol- or cysteine-proteases. Later, the discoveries of several proteins whose primary sequence revealed substantial homology to the typical cystatin domain led to the definition of a cystatin superfamily. With the identification of other types of intracellular cysteine-proteases, however, it became clear that cystatins inhibit mainly cysteine-proteases present in endosomes and lysosomes. Additionally, many of the newer members of the cystatin superfamily have less than 30 % homology to classical cystatins and do not inhibit lysosomal cysteine proteases. Moreover, several proteins with little apparent amino acid sequence homology fold into typical three-dimensional structures attributed to cystatins. Thus, the term “cystatins” now refers to a heterogeneous group of proteins still lacking both a uniform identity and a cohesive definition.

Characteristics

Domain...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Keppler D (2006) Towards novel anti-cancer strategies based on cystatin function. Cancer Lett 235:159–176

    Article  CAS  PubMed  Google Scholar 

  • Mohamed MM, Sloane BF (2006) Cysteine cathepsins: multifunctional enzymes in cancer. Nat Rev Cancer 6:764–775

    Article  CAS  PubMed  Google Scholar 

  • Muller-Esterl W, Iwanaga S, Nakanishi S (1986) Kininogens revisited. Trends Biochem Sci 11:336–339

    Article  Google Scholar 

  • Turk V, Bode W (1991) The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett 285:213–219

    Article  CAS  PubMed  Google Scholar 

  • Zabel BA, Zuniga L, Ohyama T et al (2006) Chemoattractants, extracellular proteases, and the integrated host defense response. Exp Hematol 34:1021–1032

    Article  CAS  PubMed  Google Scholar 

See Also

  • (2012) Complement. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 963. doi: 10.1007/978-3-642-16483-5_1284

    Google Scholar 

  • (2012) Cytokinesis. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1055. doi: 10.1007/978-3-642-16483-5_1477

    Google Scholar 

  • (2012) Extracellular Matrix. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1362. doi: 10.1007/978-3-642-16483-5_2067

    Google Scholar 

  • (2012) Immortalization. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1811. doi: 10.1007/978-3-642-16483-5_2969

    Google Scholar 

  • (2012) Inhibitors. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1864. doi: 10.1007/978-3-642-16483-5_3055

    Google Scholar 

  • (2012) Lung Colony Formation Assay. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2115. doi: 10.1007/978-3-642-16483-5_3436

    Google Scholar 

  • (2012) Lysosome. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2128. doi: 10.1007/978-3-642-16483-5_3472

    Google Scholar 

  • (2012) N- and O-Glycosylation. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2447. doi: 10.1007/978-3-642-16483-5_2459

    Google Scholar 

  • (2012) N- or C-Terminal Processing. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2447. doi: 10.1007/978-3-642-16483-5_5733

    Google Scholar 

  • (2012) Neovascularization. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2474. doi: 10.1007/978-3-642-16483-5_4016

    Google Scholar 

  • (2012) P53. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2747. doi: 10.1007/978-3-642-16483-5_4331

    Google Scholar 

  • (2012) Perforin. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2814. doi: 10.1007/978-3-642-16483-5_4443

    Google Scholar 

  • (2012) Phagocytosis. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2840. doi: 10.1007/978-3-642-16483-5_4493

    Google Scholar 

  • (2012) Proteases. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3080. doi: 10.1007/978-3-642-16483-5_4786

    Google Scholar 

  • (2012) Ser/Thr-Phosphorylation. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3380. doi: 10.1007/978-3-642-16483-5_5250

    Google Scholar 

  • (2012) Severe Combined Immunodeficient Mice. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3395. doi: 10.1007/978-3-642-16483-5_5271

    Google Scholar 

  • (2012) Transfection. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3757. doi: 10.1007/978-3-642-16483-5_5912

    Google Scholar 

  • (2012) Transformation. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, pp 3757–3758. doi: 10.1007/978-3-642-16483-5_5913

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lauren M. Nunez .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Nunez, L.M., Keppler, D. (2014). Cystatins. In: Schwab, M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27841-9_1450-2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-27841-9_1450-2

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Online ISBN: 978-3-642-27841-9

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics